Ramtin Agah - 07 Jun 2022 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director, 10%+ Owner
Signature
/s/ Ramtin Agah, MD
Issuer symbol
RNXT
Transactions as of
07 Jun 2022
Net transactions value
+$10,001
Form type
4
Filing time
09 Jun 2022, 06:04:33 UTC
Previous filing
14 Mar 2022
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Gift $0 -975,000 -100% $0.000000 1,295 16 Mar 2022 Direct
transaction RNXT Common Stock Gift $0 +975,000 $0.000000 975,000 16 Mar 2022 See footnote F1
transaction RNXT Common Stock Purchase $10,001 +5,182 +400% $1.93 6,477 07 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016.